SCHEMBL14536745

SCHEMBL14536745

Bc1nc(Br)cn2c(Br)cnc12

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179685 0.86 AURKA (0.30) AURKA
SCHEMBL7319030 0.74 IKBKB (0.43) AURKA
SCHEMBL7320863 0.72 HTR2C (0.41) AURKA
SCHEMBL7324280 0.71 TTK (0.38) AURKA
SCHEMBL9775094 0.69 ALDH1A1 (0.47) AURKA
SCHEMBL24714362 0.67
SCHEMBL18232238 0.67
SCHEMBL9936039 0.67
SCHEMBL14538475 0.65
SCHEMBL2181538 0.64 NPC1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2193131-B1 IMIDAZO[1,2-A]PYRAZINE COMPOUNDS FOR TREATMENT OF VIRAL INFECTIONS SUCH AS HEPATITIS BIOFOCUS DPI LTD (GB) 2013-01-30 EP disclosed
WO-2007056468-A1 METHODS FOR INHIBITING PROTEIN KINASES SCHERING CORPORATION (US) 2007-05-18 WO disclosed